-+ 0.00%
-+ 0.00%
-+ 0.00%

CRISPR THERAPEUTICS AG - SRSD107 SHOWS >93% FXI REDUCTION IN PHASE 1 TRIAL

Reuters·05/19/2025 20:15:00

Please log in to view news